asa statement on glp 1 Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: a restrictive fasting regimen is not necessary. Comment Br J Anaesth 2025; 135: 48–78 Glucagon-Like Peptide-1 Agonists and General
Description
health system given the flood of expensive drugs on the market derived from biotechnology
According to study results, GLP-1RA use was associated with a 14% decreased risk for cirrhosis compared with DPP-4i use (9.98 vs
Combining insights from the ESG Risk Rating and Morningstar Equity Research, we find that Roche and Pfizer stand out as potential top choices among the companies poised to enter the GLP-1 space
A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD
Genetics, appetite regulation, metabolism, fat storage, energy expenditure, GLP-1, GIP, leptin, ghrelin, and insulin may influence weight regulation
